Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells

European Journal of Cancer

Volumn 49, Issue 4, 2013, Pages 955-963

  Le Magnen, Clémentine ^a   Bubendorf, Lukas ^b   Ruiz, Christian ^b   Zlobec, Inti ^b   Bachmann, Alexander ^a   Heberer, Michael ^a   Spagnoli, Giulio C ^a   Wyler, Stephen ^a   Mengus, Chantal ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Cancer stem cells; Cytoplasm; Klf4; Prostate cancer

Indexed keywords

KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CELLULAR DISTRIBUTION; CYTOPLASM; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY;

BLOTTING, WESTERN; CYTOPLASM; FLUORESCENT ANTIBODY TECHNIQUE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OCTAMER TRANSCRIPTION FACTOR-3; PROGNOSIS; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOXB1 TRANSCRIPTION FACTORS; TISSUE ARRAY ANALYSIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84873714898     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.09.023     Document Type: Article

References (35)

1. A. Jemal, M.M. Center, C. Desantis, and E.M. Ward Global patterns of cancer incidence and mortality rates and trends Cancer Epidemiol Biomarkers Prev Jul 20 2010
2. T. Reya, S.J. Morrison, M.F. Clarke, and I.L. Weissman Stem cells, cancer, and cancer stem cells Nature 414 6859 2001 105 111
3. I. Ben-Porath, M.W. Thomson, and V.J. Carey An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors Nat Genet 40 5 2008 499 507
4. E.K. Markert, H. Mizuno, A. Vazquez, and A.J. Levine Molecular classification of prostate cancer using curated expression signatures Proc Natl Acad Sci USA 2011
5. M. Schoenhals, A. Kassambara, V.J. De, D. Hose, J. Moreaux, and B. Klein Embryonic stem cell markers expression in cancers Biochem Biophys Res Commun 383 2 2009 157 162
6. K. Takahashi, K. Tanabe, and M. Ohnuki Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 5 2007 861 872
7. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 4 2001 402 408
8. I. Martin, M. Jakob, D. Schafer, W. Dick, G. Spagnoli, and M. Heberer Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints Osteoarthritis Cartilage 9 2 2001 112 118
9. C. Feder-Mengus, S. Ghosh, and W.P. Weber Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes Br J Cancer 96 7 2007 1072 1082
10. D. Wei, L. Wang, and M. Kanai KLF4alpha up-regulation promotes cell cycle progression and reduces survival time of patients with pancreatic cancer Gastroenterology 2010
11. Y. Ishikawa, T. Kubota, and Y. Otani Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice Clin Cancer Res 5 4 1999 Apr 883 889
12. T. Zellweger, C. Ninck, and M. Bloch Expression patterns of potential therapeutic targets in prostate cancer Int J Cancer 113 4 2005 619 628
13. A.B. Gelb, V.A. Freeman, and S.H. Astrow Evaluation of methods for preserving PTEN antigenicity in stored paraffin sections Appl Immunohistochem Mol Morphol 19 6 2011 569 573
14. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 4 2006 663 676
15. G.D. Richardson, C.N. Robson, S.H. Lang, D.E. Neal, N.J. Maitland, and A.T. Collins CD133, a novel marker for human prostatic epithelial stem cells J Cell Sci 117 Pt 16 2004 3539 3545
16. A.T. Collins, P.A. Berry, C. Hyde, M.J. Stower, and N.J. Maitland Prospective identification of tumorigenic prostate cancer stem cells Cancer Res 65 23 2005 10946 10951
17. M.J. Pfeiffer, and J.A. Schalken Stem cell characteristics in prostate cancer cell lines Eur Urol 57 2 2010 246 254
18. B. Nagy, A. Szendroi, and I. Romics Overexpression of CD24, c-myc and phospholipase 2A in prostate cancer tissue samples obtained by needle biopsy Pathol Oncol Res 15 2 2009 279 283
19. J.A. Segre, C. Bauer, and E. Fuchs Klf4 is a transcription factor required for establishing the barrier function of the skin Nat Genet 22 4 1999 356 360
20. M. Monk, and C. Holding Human embryonic genes re-expressed in cancer cells Oncogene 20 56 2001 8085 8091
21. C.R. Jeter, M. Badeaux, and G. Choy Functional evidence that the self-renewal gene NANOG regulates human tumor development Stem Cells 27 5 2009 993 1005
22. K.W. Foster, A.R. Frost, and P. Kie-Bell Increase of GKLF messenger RNA and protein expression during progression of breast cancer Cancer Res 60 22 2000 6488 6495
23. J. Luo, T. Dunn, and C. Ewing Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis Prostate 51 3 2002 189 200
24. J. Wang, R.F. Place, and V. Huang Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration Cancer Res 70 24 2010 10182 10191
25. K.M. Bae, Z. Su, and C. Frye Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells J Urol 183 5 2010 2045 2053
26. D. Hawksworth, L. Ravindranath, and Y. Chen Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence Prostate Cancer Prostatic Dis 2010
27. Y. Li, J. McClintick, L. Zhong, H.J. Edenberg, M.C. Yoder, and R.J. Chan Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4 Blood 105 2 2005 635 637
28. P. Zhang, R. Andrianakos, Y. Yang, C. Liu, and W. Lu Kruppel-like factor 4 (KLF4) prevents embryonic stem (ES) cell differentiation by regulating nanog gene expression J Biol Chem 2010
29. B.D. Rowland, and D.S. Peeper KLF4, p21 and context-dependent opposing forces in cancer Nat Rev Cancer 6 1 2006 11 23
30. W. Zhao, I.M. Hisamuddin, M.O. Nandan, B.A. Babbin, N.E. Lamb, and V.W. Yang Identification of Kruppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer Oncogene 23 2 2004 395 402
31. W. Hu, W.L. Hofstetter, and H. Li Putative tumor-suppressive function of kruppel-like factor 4 in primary lung carcinoma Clin Cancer Res 15 18 2009 5688 5695
32. Y.J. Chen, C.Y. Wu, C.C. Chang, C.J. Ma, M.C. Li, and C.M. Chen Nuclear Kruppel-like factor 4 expression is associated with human skin squamous cell carcinoma progression and metastasis Cancer Biol Ther 7 5 2008 777 782
33. G. Narla, A. Difeo, and Y. Fernandez KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis J Clin Invest 118 8 2008 2711 2721
34. P. Sotomayor, A. Godoy, G.J. Smith, and W.J. Huss Oct4A is expressed by a subpopulation of prostate neuroendocrine cells Prostate 69 4 2009 401 410
35. G. Karoubi, L. Cortes-Dericks, M. Gugger, D. Galetta, L. Spaggiari, and R.A. Schmid Atypical expression and distribution of embryonic stem cell marker, OCT4, in human lung adenocarcinoma J Surg Oncol 2010